DACTINOMYCIN

Formula & Concentration

DACTINOMYCIN – dactinomycin 0.5 mg intravenous solution

Manufacturer

XGEN Pharmaceuticals DJB Inc.

Indications

Refractory malignant tumor of testis; gestational trophoblastic neoplasia; Kaposi’s sarcoma; Wilms’ tumor; Ewing’s sarcoma; malignancy; rhabdomyosarcoma; ovarian germ cell tumor carcinoma

Product Options

Package Size

NDC #

Presentation

0.5 mg

39822-2100-02

Vial

Shelf Life and Storage

Controlled Room Temp (20-25°C)